Par Pharmaceutical Companies, Inc. today announced it has entered into a settlement agreement with Reliant Pharmaceuticals, Inc. that resolves patent litigation related to Reliant's Rythmol(R) SR product, thereby eliminating the inherent uncertainty and costs of litigation.
The details can be read here.
No comments:
Post a Comment